2.

患者治疗方案特征分布

Characteristics of the patient treatment plans

Parameters	Ratio
Which cycle of chemotherapy
First	24.3%
Second	20.3%
Third and above	55.4%
Type of chemotherapy
Platinum based	76.4%
Nitrogen Mustards+Anthracycline	3.7%
Dacarbazine+Anthracycline	1.7%
Anthracycline based	1.0%
Others	17.2%
Pre-chemotherapy anti-emetics
Glucocorticoid	79.4%
5-hydroxytryptamine receptor antagonist	99.0%
NK-1 receptor antagonist	59.3%
Post-chemotherapy anti-emetics
Glucocorticoid	68.8%
5-hydroxytryptamine receptor antagonist	69.3%
NK-1 receptor antagonist	50.7%